LBRX
NASDAQ · Pharmaceuticals
Lb Pharmaceuticals Inc
$41.91
-0.78 (-1.83%)
Open$42.54
Previous Close$42.69
Day High$42.81
Day Low$41.43
52W High$50.16
52W Low$13.36
Volume—
Avg Volume247.3K
Market Cap1.36B
P/E Ratio—
EPS$-2.98
SectorPharmaceuticals
Analyst Ratings
Strong Buy
15 analysts
Price Target
-63.7% upside
Current
$41.91
$41.91
Target
$15.21
$15.21
$11.61
$15.21 avg
$18.52
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 167.53M | 154.99M | 171.21M |
| Net Income | 47.95M | 36.94M | 41.17M |
| Profit Margin | 28.6% | 23.8% | 24.1% |
| EBITDA | 61.52M | 61.45M | 59.09M |
| Free Cash Flow | 46.38M | 48.44M | 62.84M |
| Rev Growth | -8.2% | -9.0% | +5.4% |
| Debt/Equity | 1.06 | 1.00 | 0.91 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |